INT255635

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.20
First Reported 2008
Last Reported 2008
Negated 0
Speculated 5
Reported most in Body
Documents 1
Total Number 8
Disease Relevance 3.50
Pain Relevance 0.20

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
uterine 3
uterus 1
UFS-QOL (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 48 75.76 Quite High
Disease Link Frequency Relevance Heat
Uterine Fibroids 400 99.40 Very High Very High Very High
Disease 24 91.36 High High
Pain 48 75.76 Quite High
Myoma 8 74.32 Quite High
Keloid Scars 8 40.24 Quite Low
Fever 8 39.32 Quite Low
Incontinence 8 23.68 Low Low
Reprotox - General 1 16 19.08 Low Low
Hemorrhage 8 17.44 Low Low
Cancer 8 12.12 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The approach we used to assess the responsiveness of the UFS-QOL is consistent with that outlined by Juniper et al. [24] by addressing the following questions:
Regulation (responsiveness) of UFS-QOL
1) Confidence 0.20 Published 2008 Journal Health Qual Life Outcomes Section Body Doc Link PMC2603004 Disease Relevance 0.42 Pain Relevance 0.14
A post-hoc analysis of data from a prospective, nonrandomized, multi-center study to evaluate the safety and efficacy of MRI-guided focused ultrasound (MRgFUS) thermal ablation to treat uterine fibroids was performed to examine the responsiveness of the UFS-QOL.
Spec (examine) Regulation (responsiveness) of UFS-QOL in uterine associated with uterine fibroids
2) Confidence 0.20 Published 2008 Journal Health Qual Life Outcomes Section Body Doc Link PMC2603004 Disease Relevance 0.77 Pain Relevance 0
The responsiveness of the UFS-QOL was assessed as a post-hoc analysis of patients treated with MRI-guided focused ultrasound thermal ablation (MRgFUS) for uterine fibroids.
Regulation (responsiveness) of UFS-QOL in uterine associated with uterine fibroids
3) Confidence 0.20 Published 2008 Journal Health Qual Life Outcomes Section Abstract Doc Link PMC2603004 Disease Relevance 0.53 Pain Relevance 0
A major strength of this study is the demonstrated responsiveness of the UFS-QOL in several different analyses.
Spec (analyses) Regulation (responsiveness) of UFS-QOL
4) Confidence 0.17 Published 2008 Journal Health Qual Life Outcomes Section Body Doc Link PMC2603004 Disease Relevance 0.27 Pain Relevance 0.06
The responsiveness of the UFS-QOL was examined using effect sizes and change scores by patient-reported overall treatment effect and satisfaction.


Spec (examined) Regulation (responsiveness) of UFS-QOL
5) Confidence 0.17 Published 2008 Journal Health Qual Life Outcomes Section Abstract Doc Link PMC2603004 Disease Relevance 0.47 Pain Relevance 0
The responsiveness of the UFS-QOL was examined using patient-reported overall treatment effect at the 3-month assessment.
Spec (examined) Regulation (responsiveness) of UFS-QOL
6) Confidence 0.17 Published 2008 Journal Health Qual Life Outcomes Section Body Doc Link PMC2603004 Disease Relevance 0.05 Pain Relevance 0
Future research examining the responsiveness of the UFS-QOL with placebo-controlled alternative therapies for which the uterus remains in tact is needed to address this limitation.
Spec (examining) Regulation (responsiveness) of UFS-QOL in uterus
7) Confidence 0.17 Published 2008 Journal Health Qual Life Outcomes Section Body Doc Link PMC2603004 Disease Relevance 0.15 Pain Relevance 0
The purpose of this study was to evaluate the responsiveness of the UFS-QOL in a clinical study of treatment for uterine fibroids.


Regulation (responsiveness) of UFS-QOL in uterine associated with uterine fibroids
8) Confidence 0.17 Published 2008 Journal Health Qual Life Outcomes Section Body Doc Link PMC2603004 Disease Relevance 0.84 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox